OxThera Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 13

OxThera General Information

Description

Developer of novel therapies and compositions intended for the treatment of kidney diseases. The company leverages technology like activated bimodal enteric biotherapy to remove excess oxalate to preserve kidney function, enabling the medical community to combat kidney conditions optimally while prolonging organ functions.

Contact Information

Website
www.oxthera.com
Formerly Known As
Ixion-Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/O Ekonomi Klara Papper
  • PO Box 1062
  • 101 39 Stockholm
  • Sweden
+46 08-660
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • C/O Ekonomi Klara Papper
  • PO Box 1062
  • 101 39 Stockholm
  • Sweden
+46 08-660

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OxThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private 17-Nov-2021 Completed Clinical Trials - Phase 2
8. Later Stage VC 15-Nov-2017 Completed Clinical Trials - Phase 2
7. Later Stage VC 29-Nov-2016 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series C) 16-Apr-2014 Completed Clinical Trials - Phase 2
5. Later Stage VC 19-Sep-2012 Completed Clinical Trials - Phase 1
4. Early Stage VC 19-Nov-2007 Completed Clinical Trials - General
3. Early Stage VC 29-Jun-2007 Completed Product Development
2. Early Stage VC 11-Jul-2005 $21.2M $21.2M Completed Startup
1. Accelerator/Incubator Completed Startup
To view OxThera’s complete valuation and funding history, request access »

OxThera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapies and compositions intended for the treatment of kidney diseases. The company leverages techn
Drug Discovery
Stockholm, Sweden
21 As of 2021

Hannover, Germany
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OxThera Competitors (66)

One of OxThera’s 66 competitors is Cardior, a Formerly VC-backed company based in Hannover, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cardior Formerly VC-backed Hannover, Germany
Alcresta Therapeutics Private Equity-Backed Waltham, MA
Ability Pharma Private Equity-Backed Barcelona, Spain
Prometheus Laboratories Formerly VC-backed San Diego, CA
Dermata Formerly VC-backed San Diego, CA
You’re viewing 5 of 66 competitors. Get the full list »

OxThera Patents

  • 30

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

OxThera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-602006020347-D1 Compositions and methods for oxalate reduction Active 16-Dec-2005
CA-2633238-A1 Compositions and methods for oxalate reduction Inactive 16-Dec-2005
ES-2362897-T3 Compositions and methods for reduction of oxalate. Active 16-Dec-2005
US-8900575-B2 Compositions and methods for oxalate reduction Inactive 16-Dec-2005
US-20070184118-A1 Compositions and methods for oxalate reduction Active 16-Dec-2005 A61K9/1652
To view OxThera’s complete patent history, request access »

OxThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OxThera Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Heartcore Capital Venture Capital Minority
Flerie Venture Capital Minority
Sunstone Life Science Ventures Venture Capital Minority
Ysios Capital Venture Capital Minority
Kurma Partners Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

OxThera FAQs

  • When was OxThera founded?

    OxThera was founded in 2005.

  • Where is OxThera headquartered?

    OxThera is headquartered in Stockholm, Sweden.

  • What is the size of OxThera?

    OxThera has 21 total employees.

  • What industry is OxThera in?

    OxThera’s primary industry is Drug Discovery.

  • Is OxThera a private or public company?

    OxThera is a Private company.

  • What is OxThera’s current revenue?

    The current revenue for OxThera is .

  • How much funding has OxThera raised over time?

    OxThera has raised $117M.

  • Who are OxThera’s investors?

    Heartcore Capital, Flerie, Sunstone Life Science Ventures, Ysios Capital, and Kurma Partners are 5 of 13 investors who have invested in OxThera.

  • Who are OxThera’s competitors?

    Cardior, Alcresta Therapeutics, Ability Pharma, Prometheus Laboratories, and Dermata are some of the 66 competitors of OxThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »